AAM
ABMD

Azzad Asset Management’s Abiomed Inc ABMD Stock Holding History

Azzad Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,331
Closed -$1.8M – 402
2022
Q3 		$1.8M Hold
7,331
– – 0.18% 181
2022
Q2 		$1.81M Buy
7,331
+866
+13% +$234K 0.18% 179
2022
Q1 		$2.14M Buy
6,465
+27
+0.4% +$8.31K 0.31% 123
2021
Q4 		$2.31M Buy
6,438
+1
+0% +$338 0.31% 124
2021
Q3 		$2.1M Hold
6,437
– – 0.31% 128
2021
Q2 		$2.01M Buy
6,437
+381
+6% +$117K 0.3% 142
2021
Q1 		$1.93M Hold
6,056
– – 0.32% 125
2020
Q4 		$1.96M Buy
6,056
+2,419
+67% +$669K 0.36% 111
2020
Q3 		$1.01M Buy
+3,637
New +$1.05M 0.21% 162

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Azzad Asset Management's ABMD Position: Q4 2022 in Review

Azzad Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 7,331 shares — an estimated $1.8M sold.

Azzad Asset Management first reported a position in ABMD in Q3 2020 and held it in 9 quarters. The position peaked at $2.31M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Azzad Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Azzad Asset Management sold 7,331 Abiomed Inc shares in Q4 2022, an estimated $1.8M.
  • Azzad Asset Management first reported a position in Abiomed Inc in Q3 2020 and held it in 9 quarters.
  • Azzad Asset Management's Abiomed Inc position peaked at $2.31M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Azzad Asset Management's 13F filing for Q4 2022, filed 1 Apr 2024.